安全性,耐受性,およびALT- BB4 (新型再結合ヒアルロニダゼ) の薬理学: ランダム化,双盲,プラセボ制御,健康なボランティアにおける第1相試験
Ji Su Lee1,2, WonSerk Kim3, Chong-Hyun Won4
1Department of Dermatology, Seoul National University College of Medicine, Seoul, Republic of Korea.
Dermatology and therapy
|September 2, 2025
まとめ
再結合ヒアルロニダースであるALT- BB4は,健康な成人に皮膚下投与で優れた安全性と耐性を示した. この新しい酵素は動物由来ヒアルロニダースの有望な代替品であり,有害事象は最小限であり,抗体は検出されていません.
科学分野:
- バイオテクノロジーと医薬品科学
- 薬理学と薬物投与
背景:
- ハイアルロニダゼは,ヒアルロン酸のバリアを分解することによって,皮膚下投与を助長する.
- 動物由来ヒアルロニダゼは アナフィラキシーや動物性感染症などの危険性があります
- ALT-BB4は,ヒトのヒアルロニダースPH20から派生した新しい再結合ヒアルロニダースです.
研究 の 目的:
- 健康な成人におけるALT-BB4の安全性と耐性を評価する.
- 投与後のALT-BB4の薬動性を評価する.
- ALT- BB4の安全性をプラセボと比較する.
主な方法:
- 244人の健康な成人を対象としたランダム化,ダブルブラインド,プラセボ対照試験.
- ALT- BB4 またはプラセボの単発皮内または皮下注射
- 薬剤アレルギー反応,薬理動力学,安全性/耐受性の評価が含まれていた.
主要な成果:
- 薬剤アレルギー反応の発生率は,プラセボと比較して皮膚内ALT-BB4 (0. 4%) が低い.
- 皮下ALT-BB4は軽度で自己溶解する注射部位TEAE (16. 9%) とプラセボ (0%) を示した.
- ALT- BB4 (0. 7%) とプラセボ (5. 6%) の間では,全身性TEAEの頻度は少なく,重篤な有害事象や抗薬抗体が検出されず,全身性吸収は最小でした.
結論:
- ALT- BB4は,皮膚内投与と皮膚下投与の両方で優れた安全性と耐受性を示した.
- 動物由来ヒアルロニダースの有効な代替品として,ALT-BB4をサポートします.
- 多様な集団での発見を確認するために,さらなる臨床試験が推奨されます.
関連する概念動画
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems
331
Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
331
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Preclinical Development: Overview
4.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
174
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
174
Clinical Trials
7.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
7.8K
Phase II Reactions: Acetylation Reactions
347
Acetylation, a phase II biotransformation reaction, introduces an acetyl group to drugs or their metabolites. Acetyltransferase enzymes facilitate this reaction, which resembles α-amino acid conjugation due to the addition of a functional group to the drug molecule.
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
347


